"THP is in the business of building quality organizations through quality business practices..." - Gary Curtis, CEO Interface Associates
Our experience tells us that there are no shortcuts. Satisfied customers are the foundation to success.
We believe it is more important to look several years forward in the future, rather than a few months.
"As active board members, THP provides Althea with strategic and competitive insight to help guide growth."– Francois Ferre, Ph.D., Co-founder & Co-CEO Althea Technologies
Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a private equity firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
Accumetrics is a developer and manufacturer of point of care diagnostics in the cardiovascular and neurovascular disease areas. 
AcroMetrix is a leading developer and manufacturer of controls and standards for molecular diagnostics tests. 
Althea Technologies is a provider of contract manufacturing and services to the pharmaceutical and biotechnology industry. 
AltheaDx provides biomarker analytical and development services to pharmaceutical and biotech companies. 
Ambion is a market leader in the field of RNA-based life science research and molecular diagnostic products. 
AngioScore develops, makes and sells leading edge tools for endovascular therapy. 
Applied Precision is a leading provider of imaging, measurement and analysis systems for the life sciences industry and OEM markets. 
Asuragen is a fully integrated RNA-based therapeutic and diagnostics company with a core focus on miRNA. 
Aurora Discovery markets life sciences products including high-density microplate formats and precision nanoliter volume non-contact dispensers. 
BioVentrix is commercializing unique intellectual property enabling cardiac surgeons to treat patients with congestive heart failure by reshaping the heart. 
Confirma is a pioneer and leader in application-specific computer-aided-detection for MRI. 
Dharmacon is the global leader in synthetic RNA and related technologies. Acquired by Fisher Scientific in 2004. 
Estech develops surgical devices that enable the least invasive approach for cardiovascular surgery. 
Freedom Innovations develops, manufactures and markets premium, advanced technology prosthetic devices for lower limb amputees. Acquired by Health Evolution Partners in 2012.
Interface specializes in catheter production machines, complex medical balloon development and contract balloon manufacturing. 
Kinetikos Medical specializes in catheter production machines, complex medical balloon development and contract balloon manufacturing. 
LDR develops and markets fusion and non-fusion spinal implants to surgeons and patients on a global basis. 
MedPricer provides a technology-enabled sourcing service for hospitals that brings the benefits of real-time competition to contracting. 
NEXUS Biosystems is a developer and provider of high productivity technologies and automation products worldwide.
PneumRx is developing medical devices that assist in minimally invasive treatment of lung diseases. 
RareCyte is focused on the detection of rare cellular events, beginning with circulating tumor cells. 
SwitchGear Genomics provides technologies and reagents for understanding gene regulation and function. 
VidaCare is commercializing its FDA-approved product, EZ-IO™, for rapid, secure and safe delivery of intraosseous drugs and fluids.